Research Topic · Peer-Reviewed

Biomarkers in Cancer

Biomarkers in cancer are measurable biological molecules or features that indicate the presence of malignancy, characterize its behavior, or predict response to therapy. They may be DNA, RNA, proteins, metabolites, or histologic and immunohistochemical features detected in tumor tissue or in accessible body fluids s…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 28× across the literature 🔖 ISSN 2572-3030 🗓 Reviewed July 2026

Overview

Biomarkers in cancer are measurable biological molecules or features that indicate the presence of malignancy, characterize its behavior, or predict response to therapy. They may be DNA, RNA, proteins, metabolites, or histologic and immunohistochemical features detected in tumor tissue or in accessible body fluids such as blood, and they support detection, classification, prognosis, treatment selection, and disease monitoring. Cancer biomarkers are commonly grouped by purpose, distinguishing diagnostic markers that confirm disease, prognostic markers that estimate likely outcome, and predictive markers that anticipate benefit from a particular treatment. The molecular categories under study are diverse. Epigenetic markers, including DNA methylation changes and long non-coding RNAs, are examined in head and neck and other cancers; circulating and tissue microRNAs are evaluated for their links to progression and survival; and protein and proliferation markers assessed by immunoassay or immunohistochemistry, such as those quantifying mitotic activity, inform grading. Research in this area also encompasses immunogenomic and proteomic profiling, bioinformatic analysis of disease-associated signatures, and platforms for rigorous biomarker development and validation. A central concern is analytical and clinical validity, ensuring that a candidate marker is reproducible, specific, and meaningfully connected to patient outcomes. By translating tumor biology into quantifiable signals, biomarkers underpin earlier detection and more precise, individualized cancer care.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2018

Epigenetic Biomarkers in Head and Neck Cancer 

Gupta ShilpiCorresponding author
Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida-201313, India.
Cancer Genetics And Biomarkers Cited by 11 doi:10.14302/issn.2572-3030.jcgb-18-2428
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061
2018

Molecular Biomarkers: A Brief Review

Tarassishin LeonidCorresponding author
 Department of Biological Sciences.
Proteomics and Genomics Research doi:10.14302/issn.2326-0793.jpgr-18-2418

How this research is being cited

The 12 articles above have been cited 28 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Biomarkers in Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Cancer Genetics And Biomarkers (ISSN 2572-3030).

Journal editorial board
Dr. Charlie Gourley · United Kingdom Dr. Xinyu Chen · United States Dr. Guru Prasad Maiti · United States

This page summarises published research for orientation; it is not medical or professional advice.